Physician profile
Nicholas Stowell
NPI 1386848877
$1,901.99
in general payments reported to CMS, 2019-2025
21 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.01 · 2020: $55.21 · 2021: $141 · 2022: $151 · 2023: $533 · 2024: $455 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,467.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $435.10 | 2023-2025 | |
| Cochlear Americas | $291.34 | 2019-2022 | |
| Medtronic, INC. | $251.15 | 2023-2025 | Stealthstation S8 Platform, Propel |
| Integra Lifesciences Corporation | $179.02 | 2023-2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Glaxosmithkline, LLC. | $150.55 | 2023-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $129.75 | 2023 | Dupixent |
| Hikma Pharmaceuticals USA | $108.16 | 2022-2025 | Ryaltris |
| Ars Pharmaceuticals Operations, INC. | $59.63 | 2025 | Neffy |
| Stryker Corporation | $45.69 | 2019-2025 | Audion Et Dilation System |
| Med-El Corporation | $43.87 | 2024-2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit |
| Acclarent, INC | $29.80 | 2021-2022 | |
| Genentech USA, INC. | $21.45 | 2024 | Xolair |
| Neurent Medical Limited | $21.27 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Kaleo, INC. | $20.58 | 2024 | Auvi-Q |
| Optinose US, INC. | $19.80 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $19.47 | 2022 | |
| Phathom Pharmaceuticals, INC. | $17.71 | 2025 | Voquezna |
| Merck Sharp & Dohme LLC | $16.37 | 2023 | |
| Kala Pharmaceuticals, INC. | $16.27 | 2019 | |
| Aerin Medical INC. | $12.90 | 2019 | |
| Peerless Surgical INC. | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Stowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.